Table 3 Sociodemographic data of the study participants.
Patients | Healthy individuals | Differences | |
|---|---|---|---|
N (%) | |||
Gender [females] | 41 (50.62) | 25 (64.10) | 0.164 |
Cigarettes [smokers] | 24 (29.63) | 7 (17.95) | 0.180 |
Somatic conditions [yes] | 18 (22.22) | 11 (28.20) | 0.473 |
Mental health conditions [presence in family] | 20 (24.69) | 4 (10.26) | 0.064 |
Median (Min-Max) | |||
Age [years] | 27 (15–56) | 25 (23–32) | 0.379 |
BMI [kg/m2] | 24.58 (17.99–38.75) | 21.31 (17.71–29.12) | 0.002 |
Physical activity [min/week] | 0 (0-1440) | 45 (0-630) | 0.005 |
Duration of illness [years] | 5 (1–31) | N/A | N/A |
Hospitalizations [number] | 2 (0–15) | N/A | N/A |
Olanzapine equivalents [to 1 mg OLA] | 25 (0.63–135) | N/A | N/A |
PANSS [total points] | 74 [36–145] | N/A | N/A |